Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis. (November 2018)
- Record Type:
- Journal Article
- Title:
- Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis. (November 2018)
- Main Title:
- Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis
- Authors:
- Liu, Ying-ying
Shi, Yao
Liu, Ya
Pan, Xing-hua
Zhang, Ke-xiong - Abstract:
- Abstract Telomere shortening is associated with idiopathic pulmonary fibrosis (IPF), a high-morbidity and high-mortality lung disease of unknown etiology. However, the underlying mechanisms remain largely unclear. In this study, wild-type (WT) mice with normal telomeres and generation 3 (G3) or G2 telomerase RNA component (TERC) knockoutTerc − /− mice with short telomeres were treated with and without lipopolysaccharide (LPS) or bleomycin by intratracheal injection. We show that under LPS induction, G3Terc − /− mice develop aggravated pulmonary fibrosis as indicated by significantly increased α-SMA, collagen I and hydroxyproline content. Interestingly, TGF-β/Smads signaling is markedly activated in the lungs of G3Terc − /− mice, as indicated by markedly elevated levels of phosphorylated Smad3 and TGF-β1, compared with those of WT mice. This TGF-β/Smads signaling activation is significantly increased in the lungs of LPS-treated G3Terc − /− mice compared with those of LPS-treated WT or untreated G3Terc − /− mice. A similar pattern of TGF-β/Smads signaling activation and the enhancing role of telomere shortening in pulmonary fibrosis are also confirmed in bleomycin-induced model. Moreover, LPS challenge produced more present cellular senescence, apoptosis and infiltration of innate immune cells, including macrophages and neutrophils in the lungs of G3Terc − /− mice, compared with WT mice. To our knowledge, this is the first time to report telomere shortening activatedAbstract Telomere shortening is associated with idiopathic pulmonary fibrosis (IPF), a high-morbidity and high-mortality lung disease of unknown etiology. However, the underlying mechanisms remain largely unclear. In this study, wild-type (WT) mice with normal telomeres and generation 3 (G3) or G2 telomerase RNA component (TERC) knockoutTerc − /− mice with short telomeres were treated with and without lipopolysaccharide (LPS) or bleomycin by intratracheal injection. We show that under LPS induction, G3Terc − /− mice develop aggravated pulmonary fibrosis as indicated by significantly increased α-SMA, collagen I and hydroxyproline content. Interestingly, TGF-β/Smads signaling is markedly activated in the lungs of G3Terc − /− mice, as indicated by markedly elevated levels of phosphorylated Smad3 and TGF-β1, compared with those of WT mice. This TGF-β/Smads signaling activation is significantly increased in the lungs of LPS-treated G3Terc − /− mice compared with those of LPS-treated WT or untreated G3Terc − /− mice. A similar pattern of TGF-β/Smads signaling activation and the enhancing role of telomere shortening in pulmonary fibrosis are also confirmed in bleomycin-induced model. Moreover, LPS challenge produced more present cellular senescence, apoptosis and infiltration of innate immune cells, including macrophages and neutrophils in the lungs of G3Terc − /− mice, compared with WT mice. To our knowledge, this is the first time to report telomere shortening activated TGF-β/Smads signaling in lungs. Our data suggest that telomere shortening cooperated with environment-induced lung injury accelerates the development of pulmonary fibrosis, and telomere shortening confers an inherent enhancing factor to the genesis of IPF through activation of TGF-β/Smads signaling. … (more)
- Is Part Of:
- Acta pharmacologica Sinica. Volume 39:Number 11(2018)
- Journal:
- Acta pharmacologica Sinica
- Issue:
- Volume 39:Number 11(2018)
- Issue Display:
- Volume 39, Issue 11 (2018)
- Year:
- 2018
- Volume:
- 39
- Issue:
- 11
- Issue Sort Value:
- 2018-0039-0011-0000
- Page Start:
- 1735
- Page End:
- 1745
- Publication Date:
- 2018-11
- Subjects:
- telomerase -- telomere shortening -- TGF-β/Smads -- pulmonary fibrosis -- lipopolysaccharide -- bleomycin
Pharmacology -- Periodicals
615.105 - Journal URLs:
- http://bibpurl.oclc.org/web/6318 ↗
http://firstsearch.oclc.org ↗
http://www.blackwell-synergy.com/loi/aphs ↗
http://www.chinaphar.com ↗
http://www.nature.com/aps/archive/index.html ↗
http://www.nature.com/ ↗
http://www.blackwell-synergy.com/loi/aphs ↗ - DOI:
- 10.1038/s41401-018-0007-9 ↗
- Languages:
- English
- ISSNs:
- 1671-4083
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0648.100000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10800.xml